|
Code
|
7250A
|
|
MA number
|
29/0383/13-S
|
|
Product Form:
|
gra mdf 70x1,5 g (vre.PES/Al/PE)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Dr. Falk Pharma GmbH, Germany
|
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
|
ATC:
|
| A |
ALIMENTARY TRACT AND METABOLISM |
| A07 |
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/INTESTINAL ANTIINFECTIVES |
| A07E |
INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EC |
Aminosalicylic acid and similar agents |
| A07EC02 |
Mesalazine |
|
|
Shelf life:
|
48 |
|
Container:
|
sachet PE/Al/PES
|
|
Route of admin.:
|
Oral use
|
SPC_Salofalk granulát s predĺženým uvoľňovaním_03.2023.pdf
